If you enjoy this content, please share it with a colleague
RELATED CONTENT
June 12, 2009 - Digirad Corp., a provider of medical diagnostic imaging products and personnel and equipment leasing services, will feature at SNM its recently 510(k) cleared Cardius X-ACT imaging system.
March 26, 2009 - Digirad Corp. has received 510(k) clearance from the FDA to market and manufacture its Cardius X-ACT imaging system.
Digirad's Cardius X-ACT, a dedicated cardiac SPECT system, offers the potential to set new clinical standards with X-ACT attenuation correction. The X-ACT system is based on the high-efficiency Cardius-3 XPO triple-head upright dedicated nuclear cardiac SPECT imaging system.
September 23, 2008 - Digirad Corp. yesterday announced FDA clearance of its nSPEED reconstruction software, to be used ...
September 5, 2008 - Digirad Corp. today announced the initial clinical trial of its new SPECT imaging system ...
Digirad Corp. presents its 2020tc Imager, a solid-state gamma camera, which is compact, lightweight and designed to ...